These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 18057188

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predicting utility for joint health states: a general framework and a new nonparametric estimator.
    Bo Hu, Fu AZ.
    Med Decis Making; 2010; 30(5):E29-39. PubMed ID: 20643911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example.
    Elkin EB, Cowen ME, Cahill D, Steffel M, Kattan MW.
    Med Decis Making; 2004; 24(5):504-10. PubMed ID: 15358999
    [Abstract] [Full Text] [Related]

  • 7. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E, Bill-Axelson A, Holmberg L, Onelöv E, Johansson JE, Steineck G, Scandinavian Prostate Cancer Group Study No 4.
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
    Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y.
    Cancer; 2008 Mar 01; 112(5):1058-65. PubMed ID: 18186497
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Implications of spillover effects within the family for medical cost-effectiveness analysis.
    Basu A, Meltzer D.
    J Health Econ; 2005 Jul 01; 24(4):751-73. PubMed ID: 15960995
    [Abstract] [Full Text] [Related]

  • 12. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H.
    Health Econ; 2002 Jul 01; 11(5):447-56. PubMed ID: 12112493
    [Abstract] [Full Text] [Related]

  • 13. A new and more robust test of QALYs.
    Doctor JN, Bleichrodt H, Miyamoto J, Temkin NR, Dikmen S.
    J Health Econ; 2004 Mar 01; 23(2):353-67. PubMed ID: 15019761
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S.
    Contemp Clin Trials; 2009 Jan 01; 30(1):81-7. PubMed ID: 18783735
    [Abstract] [Full Text] [Related]

  • 16. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study.
    Schmitt J, Meurer M, Klon M, Frick KD.
    Br J Dermatol; 2008 Feb 01; 158(2):351-9. PubMed ID: 18070214
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A nonparametric elicitation of the equity-efficiency trade-off in cost-utility analysis.
    Bleichrodt H, Doctor J, Stolk E.
    J Health Econ; 2005 Jul 01; 24(4):655-78. PubMed ID: 15960990
    [Abstract] [Full Text] [Related]

  • 19. Utility measures of health-related quality of life in patients treated for benign paroxysmal positional vertigo.
    Roberts RA, Abrams H, Sembach MK, Lister JJ, Gans RE, Chisolm TH.
    Ear Hear; 2009 Jun 01; 30(3):369-76. PubMed ID: 19322083
    [Abstract] [Full Text] [Related]

  • 20. Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis.
    Neuman HB, Elkin EB, Guillem JG, Paty PB, Weiser MR, Wong WD, Temple LK.
    Dis Colon Rectum; 2009 May 01; 52(5):863-71. PubMed ID: 19502849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.